{"id":"https://openalex.org/W2068370293","doi":"https://doi.org/10.1111/j.1463-1326.2008.00880.x","title":"Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients","display_name":"Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients","alternate_titles":[],"publication_year":2008,"publication_date":"2008-10-29","ids":{"openalex":"https://openalex.org/W2068370293","doi":"https://doi.org/10.1111/j.1463-1326.2008.00880.x","mag":"2068370293","pmid":"https://pubmed.ncbi.nlm.nih.gov/18476983"},"language":"en","primary_location":{"id":"doi:10.1111/j.1463-1326.2008.00880.x","doi":"https://doi.org/10.1111/j.1463-1326.2008.00880.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2008.00880.x","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2068370293"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109858147","display_name":"Y. Miyazaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Y. Miyazaki","raw_affiliation_strings":["Department of Medicine, Diabetes Division, University of Texas Health Science Center, San Antonio, TX 78229-3900, USA","University of Texas Health Science Center, San Antonio, Department of Medicine, Diabetes Division, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Diabetes Division, University of Texas Health Science Center, San Antonio, TX 78229-3900, USA","institution_ids":["https://openalex.org/I165951966"]},{"raw_affiliation_string":"University of Texas Health Science Center, San Antonio, Department of Medicine, Diabetes Division, TX, USA","institution_ids":["https://openalex.org/I165951966"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091912602","display_name":"Ralph A. DeFronzo","orcid":"https://orcid.org/0000-0003-3839-1724","observed_orcids":["https://orcid.org/0000-0003-3839-1724"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"R. A. DeFronzo","raw_affiliation_strings":["University of Texas Health Science Center, San Antonio, Department of Medicine, Diabetes Division, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Health Science Center, San Antonio, Department of Medicine, Diabetes Division, TX, USA","institution_ids":["https://openalex.org/I165951966"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5091912602"],"corresponding_institution_ids":["https://openalex.org/I165951966"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":4.6777,"has_fulltext":false,"cited_by_count":96,"citation_normalized_percentile":{"value":0.95378928,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"10","issue":"12","first_page":"1204","last_page":"1211"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9042999744415283,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9042999744415283,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.050999999046325684,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.02969999983906746,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rosiglitazone","display_name":"rosiglitazone","score":0.9929999709129333},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":1.0},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.8859999775886536},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9980000257492065},{"id":"https://openalex.org/keywords/insulin-sensitivity","display_name":"insulin sensitivity","score":0.9829999804496765},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.9660000205039978},{"id":"https://openalex.org/keywords/glucose-tolerance","display_name":"glucose tolerance","score":0.7789999842643738},{"id":"https://openalex.org/keywords/adipokines","display_name":"adipokines","score":0.9470000267028809},{"id":"https://openalex.org/keywords/adiponectin","display_name":"adiponectin","score":0.8500000238418579},{"id":"https://openalex.org/keywords/leptin","display_name":"leptin","score":0.9210000038146973},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9419999718666077},{"id":"https://openalex.org/keywords/insulinogenic-index","display_name":"insulinogenic index","score":0.6589999794960022},{"id":"https://openalex.org/keywords/matsuda-index","display_name":"Matsuda index","score":0.9760000109672546},{"id":"https://openalex.org/keywords/free-fatty-acids","display_name":"free fatty acids","score":0.7440000176429749},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.7979999780654907},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.6700000166893005},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.6380000114440918}],"concepts":[{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.9398847818374634},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.9198857545852661},{"id":"https://openalex.org/C2780152017","wikidata":"https://www.wikidata.org/wiki/Q424771","display_name":"Rosiglitazone","level":3,"score":0.887769341468811},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.8720360398292542},{"id":"https://openalex.org/C2776782570","wikidata":"https://www.wikidata.org/wiki/Q357439","display_name":"Adiponectin","level":4,"score":0.7709997892379761},{"id":"https://openalex.org/C194832188","wikidata":"https://www.wikidata.org/wiki/Q2638593","display_name":"Adipokine","level":4,"score":0.6683568358421326},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6451808214187622},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.5973016619682312},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.5787642002105713},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5085650682449341},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4976048767566681},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.45861271023750305},{"id":"https://openalex.org/C2780613262","wikidata":"https://www.wikidata.org/wiki/Q223739","display_name":"Leptin","level":3,"score":0.4529111385345459},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4145803451538086},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.21043476462364197},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.13022005558013916}],"mesh":[{"descriptor_ui":"D000077154","descriptor_name":"Rosiglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077205","descriptor_name":"Pioglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005951","descriptor_name":"Glucose Tolerance Test","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D007333","descriptor_name":"Insulin Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019518","descriptor_name":"Postprandial Period","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D054392","descriptor_name":"Adipokines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1463-1326.2008.00880.x","doi":"https://doi.org/10.1111/j.1463-1326.2008.00880.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2008.00880.x","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:18476983","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18476983","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W91098912","https://openalex.org/W1492605893","https://openalex.org/W1587875569","https://openalex.org/W1973245422","https://openalex.org/W1977004017","https://openalex.org/W1982990554","https://openalex.org/W1994090821","https://openalex.org/W1999236387","https://openalex.org/W2000821877","https://openalex.org/W2003323316","https://openalex.org/W2015495335","https://openalex.org/W2027107698","https://openalex.org/W2031125972","https://openalex.org/W2031773477","https://openalex.org/W2036939737","https://openalex.org/W2062560800","https://openalex.org/W2070367531","https://openalex.org/W2076641670","https://openalex.org/W2079368549","https://openalex.org/W2100514340","https://openalex.org/W2102675827","https://openalex.org/W2107298817","https://openalex.org/W2110804432","https://openalex.org/W2117205405","https://openalex.org/W2125344994","https://openalex.org/W2127125241","https://openalex.org/W2129316761","https://openalex.org/W2133795831","https://openalex.org/W2143991719","https://openalex.org/W2146845495","https://openalex.org/W2148403865","https://openalex.org/W2150600184","https://openalex.org/W2157115138","https://openalex.org/W2159083249","https://openalex.org/W2159969745","https://openalex.org/W2160234571","https://openalex.org/W2166226788","https://openalex.org/W2170932033","https://openalex.org/W2171968999","https://openalex.org/W2277672822","https://openalex.org/W2337454357","https://openalex.org/W2752336761","https://openalex.org/W2760875141","https://openalex.org/W4240449862"],"related_works":["https://openalex.org/W2354214543","https://openalex.org/W2350630869","https://openalex.org/W2031125972","https://openalex.org/W2160638574","https://openalex.org/W2049020109","https://openalex.org/W1890165263","https://openalex.org/W1981278690","https://openalex.org/W2375712612","https://openalex.org/W2107925124","https://openalex.org/W2378797645"],"abstract_inverted_index":{"OBJECTIVE:":[0],"We":[1],"examined":[2],"the":[3,272],"effects":[4,252],"of":[5,10,23,149],"rosiglitazone":[6,91,99,197],"treatment":[7,25],"on":[8,253,271],"profiles":[9],"adipocytokines":[11,58],"levels,":[12,19],"postprandial":[13],"insulin":[14,150,256,258],"and":[15,57,64,122,131,146,153,178,203,237,247,260],"glucose":[16,50,104],"excursion,":[17],"lipids":[18],"comparing":[20],"with":[21,28,72],"those":[22],"pioglitazone":[24,93,220,248,265],"in":[26,36,68,162],"patients":[27,70],"type":[29],"2":[30],"diabetes":[31],"mellitus":[32],"(T2DM).":[33],"METHODS:":[34],"Changes":[35],"body":[37,163],"weight,":[38],"haemoglobin":[39],"A(1c":[40],")(HbA(1c)),":[41],"glucose/insulin/C-peptide/free":[42],"fatty":[43],"acid":[44],"(FFA)":[45],"during":[46],"75":[47],"g":[48],"oral":[49],"tolerance":[51],"test":[52],"(OGTT),":[53],"HDL-/LDL-cholesterol,":[54],"triglyceride":[55],"(TG)":[56],"[tumour":[59],"necrosis":[60],"factor":[61],"(TNF)-alpha,":[62],"leptin":[63,189],"adiponectin]":[65],"were":[66,133],"measured":[67],"T2DM":[69],"treated":[71],"rosiglitazone,":[73],"8":[74],"mg/day":[75,82],"(n":[76,83],"=":[77,84],"35),":[78],"or":[79,92],"pioglitazone,":[80],"45":[81],"21),":[85],"for":[86],"3":[87],"months.":[88],"RESULTS:":[89],"After":[90,196,219],"treatment,":[94,198,221],"HbA(1c":[95],")(8.6-7.2":[96],"vs.":[97,100,106,112,119,126,144,166,171,181],"8.3-6.9%,":[98],"pioglitazone),":[101],"fasting":[102,109],"plasma":[103,116,199,222,261,273],"(190-144":[105],"178-140":[107],"mg/dl),":[108],"FFA":[110],"(729-595":[111],"641-526":[113],"microEq/l),":[114],"mean":[115,123],"glucose-OGTT":[117],"(292-229":[118],"285-233":[120],"mg/dl)":[121,202,206,214,225,233,240],"FFA-OGTT":[124],"(580-430":[125],"488-377":[127],"microEq/l)":[128],"decreased":[129,174,241],"similarly":[130],"all":[132],"statistically":[134],"significant":[135],"(p":[136,156,175,185,208,227,242],"<":[137,157,176,186,209,228,243],"0.01).":[138,244],"The":[139],"insulinogenic":[140],"index":[141,148],"(DeltaI(0-120)/DeltaG(0-120))":[142],"(0.19-0.30":[143],"0.17-0.26)":[145],"Matsuda":[147],"sensitivity":[151],"(2.0-3.1":[152],"2.7-4.3)":[154],"increased":[155,184,207,226],"0.01)":[158],"similarly,":[159],"despite":[160],"increase":[161],"weight":[164],"(85-88":[165],"81-84":[167],"kg).":[168],"TNF-alpha":[169],"(3.8-3.4":[170],"5.2-4.5":[172],"pg/ml)":[173],"0.05)":[177],"adiponectin":[179],"(6.3-17.8":[180],"7.1-16.4":[182],"microg/ml)":[183],"0.01),":[187,210],"while":[188,211,230],"did":[190,215,234],"not":[191,216,235],"change":[192,217,236],"following":[193],"either":[194],"treatment.":[195],"HDL-cholesterol":[200,223],"(34-38":[201],"LDL-cholesterol":[204,231],"(103-120":[205],"TGs":[212,238],"(177-167":[213],"significantly.":[218],"(34-37":[224],"0.05),":[229],"(104-105":[232],"(153-106":[239],"CONCLUSIONS:":[245],"Rosiglitazone":[246],"have":[249],"similar":[250],"beneficial":[251,269],"glycaemic":[254],"control":[255],"sensitivity,":[257],"secretion":[259],"adipocytokine":[262],"levels.":[263],"However,":[264],"has":[266],"a":[267],"more":[268],"effect":[270],"lipid":[274],"profile":[275],"than":[276],"rosiglitazone.":[277]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2068370293","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":15},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
